03/23/2026 04:00
Paving the Way for Real‑Time Earth Observation: Space Compass and SWISSto12 Sign Contract for First Commercial GEO Optical Data Relay Satellite

Space Compass Corporation (“Space Compass”) and SWISSto12 SA (“SWISSto12”) announced today that they have executed a procurement contract for the first GEO optical data relay satellite. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260320584108/en/(From Left to Right): Julie Pignon, Legal Counsel, SWISSto12; 倉田 るり子 (Ruriko Kurata), Legal Counsel, Space Compass; 小松 大実 (Hiromi Komatsu), Co-CEO, Space Compass; 田中 良太 (Ryota Tanaka), En...

03/27/2026 16:30
Credit Derivatives Determinations Committees Membership applications for 2026

DC Administration Services, Inc. (DCAS) would like to invite all interested Members of ISDA to apply for a position as a member of the Credit Derivatives Determinations Committees. There is a separate Determinations Committee for each of the relevant regions. Members of ISDA may apply for membership as either a Dealer Member of the Determinations Committees or a Non-Dealer Member of the Determinations Committees (as applicable). Parties wishing to apply for such a position should carefully re...

04/01/2026 04:30
RevolKa Reimagines Antibody Engineering with "RevoAb®"

RevolKa Ltd. (RevolKa), a venture-backed biotech company providing an advanced AI protein engineering technology platform, called aiProtein®, is pleased to announce the official global launch of RevoAb®, an innovative and quick online service for antibody sequence optimization to solve challenges in physicochemical properties, especially antibody yields. RevoAb®: The Next-Gen AI Antibody Design Since December 2023, RevolKa has provided an antibody optimization services utilizing aiProtein®....

AFP’s 2024 financial results: turnover growth of 2 percent and positive net profits for sixth straight year

During its meeting on April 29, 2025, AFP’s board approved the 2024 accounts, which confirm the positive financial trajectory the Agency has been on for seven years.

During its meeting on April 29, 2025, AFP’s board approved the 2024 accounts, which confirm the positive financial trajectory the Agency has been on for seven years.
Anglais
03/25/2026 00:00
Avia Establishes Global Trust Center in Singapore

AviaGames today announced the opening of its Global Trust Center in Singapore, a dedicated hub for advancing security and data protection for players across its portfolio of skill-based, real-money games. Dr. Jan Wang, Chief Information Security Officer, AviaGames, will oversee the entity, bringing experience from security leadership roles at highly regulated organizations such as AWS (Amazon Web Services) to build a high-performance cybersecurity team and lead complex international regulatory ...

04/09/2026 12:00
SLB OneSubsea Awarded Contract for Shenandoah Field

Global energy technology company SLB (NYSE: SLB) announced that its SLB OneSubsea joint venture was awarded a contract by Beacon Offshore Energy (BOE) Exploration and Production LLC to deliver a high‑pressure, high‑temperature (HPHT) multiphase boosting system for the Shenandoah field in the Gulf of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260408082460/en/SLB (NYSE: SLB) announced that its SLB OneSubsea joint venture ...

04/09/2026 13:00
$300 Billion in Life Sciences Revenue at Risk. The Intelligence Behind It Is Months Old. Behavior Labs Launches a Decision Intelligence Platform That Addresses This Gap.

Behavior Labs, a new life sciences intelligence company, today launched a platform that gives pharmaceutical and medical device teams continuous strategic intelligence — powered by what the company calls a World Model, a continuously operating model of the market reality each product exists in. The platform replaces quarterly review cycles with daily, cross-validated insight across the full product lifecycle, from patent cliff defence and biosimilar war-gaming to regulatory pathway optimisation...